SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?


To: Peter Goss who wrote (5037)5/18/1999 1:04:00 AM
From: Gerald F Bunch  Respond to of 5736
 
Peter

This is probably the safest short available at this time. Strangely enough it MAY still have some upward potential, but what the heck if you don't need the money now give it a year or two and and you can recover your investment plus a hundred %. Unfortunately, that is the bad thing about shorting any stock, all you can expect is 100% return (a 2 bagger is small potatoes) Oh well

Best Regards
GB



To: Peter Goss who wrote (5037)5/18/1999 3:45:00 AM
From: jpbrody  Read Replies (2) | Respond to of 5736
 
Peter, I have to say that objectively all the points you made were true except:

they are burning cash faster than they can find new sources of financing

Somehow, they keep raising cash and stay afloat. I was short this stock about a year ago, before Asensio starting issuing his press releases and I thought that was the end of CCSI. But the stock price somehow recovered.

I would not buy this stock, because it seems overvalued to me. But I think that someone is doing a fine job of selling the stock to the public, which is driving the price up. My take on it is that it's a story that people want to believe. Some people have trouble putting numbers together and estimating potential profits/sales, and if you get someone like that and tell them the story of CCSI (new technology to measure bilirubin in babies, no more heelsticks, etc) they'll buy into it.

So, I think that in the long run I believe the company won't make enough money to justify it's current valuation, but in the short run it could still go substantially higher than it's current valuation.

Jim<